OrderlyMeds announces 3 month subscription plans for compounded semaglutide starting at $74 monthly for new GLP-1 users. The telehealth service offers personalized formulations with supportive additives which can be delivered directly to the patient's home address.
-- OrderlyMeds has introduced two distinct subscription plans designed to make compounded semaglutide more accessible for individuals seeking weight loss support. The company now offers a SimpleStart program at $74 per month for new GLP-1 users, totaling $224 for three months. Monthly plans are also available at $149 per month for those currently taking a GLP-1 medication. These transparent pricing tiers address the growing demand for affordable alternatives to brand-name weight loss medications, which often carry higher costs.
More information is available at https://orderlymeds.com/pricing/
Interest in GLP-1 medications for weight management has surged as successive clinical data demonstrates their efficacy. Real-world studies of compounded semaglutide show an average weight loss of 9.11 percent after four months in digital weight-loss programs. The effectiveness of semaglutide has encouraged millions of Americans to try it: recent estimates state that around 6% of U.S. adults currently take GLP-1s.
This has led to many FDA-approved brand names and scientifically backed alternatives flooding the market. However, OrderlyMeds differentiates its offering through personalized formulations that include supportive additives tailored to individual health screenings. Based on patient needs, compounded semaglutide may incorporate Vitamin B6 and B12 to support digestive comfort and energy levels. Additional components such as B12 may aid in muscle repair during weight loss and consistent energy as the body adapts to slower digestion and reduced calorie intake.
The company delivers these personalized formulations through a streamlined telehealth model that eliminates geographic barriers and pharmacy visits. OrderlyMeds provides compounded GLP-1 injections in all 50 states through an online health screening process, working with licensed providers for a prescription, that ships medications directly to patients' doors.
Clinical eligibility criteria ensure appropriate patient selection and regulatory compliance, explains Orderly Meds. Patients must be 18 years or older and have a BMI greater than 25 (or greater than 20 if already on GLP-1 medication). Certain medical conditions, including thyroid cancer, gastroparesis, MEN2 syndrome, or inflammatory bowel disease, will disqualify them from the service.
Interested individuals can check eligibility and begin the process through the online portal, where licensed providers offer real-time support and community access throughout the treatment process.
For more details, visit https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89181399
If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.
